All Stories

  1. Latent profile analysis identifies four different clinical schizophrenia profiles through aberrant salience
  2. Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database
  3. Obsessive–Compulsive Disorder as an Epiphenomenon of Comorbid Bipolar Disorder? An Updated Systematic Review
  4. Influence of NUCB/Nesfatin-1 Polymorphism on Treatment Response to Naltrexone/Bupropion SR in Binge Eating Disorder and Obesity
  5. Using latent class analysis to identify different clinical profiles according to food addiction symptoms in obesity with and without binge eating disorder
  6. Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
  7. Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database
  8. Head Regional Differences in Thermal Comfort: Evaluating a Novel Surgical Helmet Cooling Method with Phase Change Material
  9. Pain experience in eating disorders: The mediating role of depression, alexithymia and interoceptive awareness
  10. Cognitive biases are associated with aberrant salience experience in schizophrenia spectrum disorders
  11. Defining the minimum clinically important difference (MCID) in the hospital anxiety and depression scale (HADS) in patients undergoing total hip and knee arthroplasty
  12. Esketamine nasal spray in severe bipolar depression with borderline personality disorder and history of multiple substance abuse: A case report
  13. Sleep Disturbances in Panic Disorder with Comorbid Complex PTSD: A Possible Relationship and Different Psychopathology?
  14. Effectiveness of SGA-LAIs on Clinical, Cognitive, and Social Domains in Schizophrenia: Results from a Prospective Naturalistic Study
  15. Sleep Disturbances in Generalized Anxiety Disorder: The Role of Calcium Homeostasis Imbalance
  16. Postoperative psychological factors and quality of life but not shoulder brace adherence affect clinical outcomes after arthroscopic rotator cuff repair
  17. Mental health-related stigma in movies: A call for action to the cinema industry
  18. The Mediation Effect of Peripheral Biomarkers of Calcium Metabolism and Chronotypes in Bipolar Disorder Psychopathology
  19. Brain stimulation and other biological non-pharmacological interventions in mental disorders: An umbrella review
  20. Validation of a novel Psychosis-Implicit Association Test (P-IAT) as a diagnostic support tool
  21. Is everyone invited to the discussion table? A Bibliometric Analysis COVID-19 Related Mental Health Literature
  22. Aberrant salience correlates with psychotic dimensions in outpatients with schizophrenia spectrum disorders
  23. Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases
  24. THE RISING SCOURGE OF MENTAL ILLNESS AND INFODEMIC: AN OUTCOME OF SOCIAL MEDIA AND COVID-19
  25. EFFECTS OF THE GLOBAL ECOLOGICAL CRISIS ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS: AN INTERNATIONAL PERSPECTIVE
  26. The grief experience during the COVID-19 pandemic across different cultures
  27. Associations of lockdown stringency and duration with Google searches for mental health terms during the COVID-19 pandemic: A nine-country study
  28. Depression and anxiety among Pakistani healthcare workers amid COVID-19 pandemic: A qualitative study
  29. Nicotine replacement gums dependence: A case report of a new potential addiction
  30. Palatal myoclonus with tinnitus treated as a psychogenic disorder for 35-years
  31. Primary Obsessive Slowness: A Complex Presentation and Treatment Difficulties
  32. Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis
  33. Pharmacovigilance approaches to study rare and very rare side-effects: the example of clozapine-related DiHS/DRESS syndrome
  34. Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis
  35. Support the frontliners – good initiatives during the COVID-19 pandemic for healthcare workers across the world: is this what we really need?
  36. Scaling Up Global Mental Health Services During the COVID-19 Pandemic and Beyond
  37. Development, validation and clinical use of the Eating Behaviors Assessment for Obesity (EBA-O)
  38. The Mental Health of Caregivers and Their Patients With Dementia During the COVID-19 Pandemic: A Systematic Review
  39. Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease
  40. How to overcome barriers to publication in low‐ and middle‐income countries: Recommendations from early career psychiatrists and researchers from around the world
  41. How is the COVID-19 pandemic affecting women's menstrual cycles and quality of life? A view from South Asia
  42. Awareness of illness moderates self-assessment of psychotic symptoms
  43. Prevalence of impaired kidney function in patients with long‐term lithium‐treatment: a systematic review and meta‐analysis
  44. Dissociative Symptoms in Bipolar Disorder: Impact on Clinical Course and Treatment Response
  45. Olanzapine-Related Somnambulism
  46. La représentation des femmes dans les comités éditoriaux des revues de psychiatrie : multiples défis et obstacles
  47. Fear During COVID-19 pandemic: Fear of COVID-19 Scale Measurement Properties
  48. Mental status via telepsychiatry: The potential pitfalls
  49. Suicidal behavior sociocultural factors in developing countries during COVID-19
  50. Role of Social Media in Psychiatry During Pandemic
  51. A systematic review and pooled, patient‐level analysis of predictors of mortality in neuroleptic malignant syndrome
  52. Impact of videoconferencing applications on mental health
  53. Core clinical manifestations of clozapine-related DRESS syndrome: A network analysis
  54. Executive functions and depressive symptoms interplay in binge eating disorder: A structural equation model analysis
  55. Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile
  56. Neuroimaging correlates of insight in non-affective psychosis: A systematic review and meta-analysis
  57. Suicide is multifactorial: There should be a difference between a news report and a scientific report of suicide
  58. Coronavirus outbreak from early career psychiatrists' viewpoint: What we have learned so far
  59. Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review
  60. Challenges and Opportunities of Psychiatric Training During COVID-19: Early Career Psychiatrists’ Perspective Across the World
  61. Current and emerging long-acting antipsychotics for the treatment of schizophrenia
  62. Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression
  63. Internet and Pornography Use During the COVID-19 Pandemic: Presumed Impact and What Can Be Done
  64. COVID-19 & psychiatric care: Need of a plan to prevent follow-up discontinuation
  65. Antisocial Personality Disorder in Bipolar Disorder: A Systematic Review
  66. Clinical Impact of Psychopathy on Bipolar Disorder
  67. Telepsychiatry in Low- and Middle-Income Countries During COVID-19
  68. Matrix Metalloproteinase 9 Blood Alterations in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis
  69. Current state of cannabis use, policies, and research across sixteen countries: Cross-Country Comparisons and International perspectives
  70. 24-hour mobile phone helpline service for women discharged from mother-baby psychiatry unit (MBU): Is it possible?
  71. IMPACT OF BIPOLAR DISORDER AND OBSESSIVE-COMPULSIVE DISORDER COMORBIDITY ON NEUROCOGNITIVE PROFILE: A MINI-REVIEW
  72. It’s COVID o’clock—time to publish or perish
  73. Development and Validation of a Computerized Adaptive Assessment Tool for Discrimination and Measurement of Psychotic Symptoms
  74. Effect of COVID-19 on Mental Health Rehabilitation Centers
  75. Infectious disease outbreak related stigma and discrimination during the COVID-19 pandemic: Drivers, facilitators, manifestations, and outcomes across the world
  76. Management of psychiatric conditions and delirium during the COVID-19 pandemic across continents: The lessons thus far
  77. Pathways to orthorexia nervosa: a case series discussion
  78. The urge to implement and expand telepsychiatry during the COVID-19 crisis: Early career psychiatrists’ perspective
  79. Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review
  80. Application of Support Vector Machine on fMRI Data as Biomarkers in Schizophrenia Diagnosis: A Systematic Review
  81. La urgencia de implementar y ampliar la telepsiquiatría durante la crisis de COVID-19: perspectiva de los psiquiatras que inician su carrera
  82. An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder
  83. Second-generation long-acting injections anti-psychotics improve executive functions in patients with schizophrenia: a 12-month real-world study
  84. Sleep Disturbance in Bipolar Disorder: Neuroglia and Circadian Rhythms
  85. ‘Impaired Autonomy and Performance’ predicts binge eating disorder among obese patients
  86. Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review
  87. Weight and age do not account for a worse executive functioning among BED-obese patients
  88. Effectiveness of integrated psychological therapy on clinical, neuropsychological, emotional and functional outcome in schizophrenia: a RCT study
  89. Bipolar disorder and obsessive compulsive disorder: The comorbidity does not further impair the neurocognitive profile